Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations

New England Journal of Medicine

Volumn 373, Issue 15, 2015, Pages 1429-1436

  Teo, Ada E D ^a   Garg, Sumedha ^a   Shaikh, Lalarukh Haris ^a   Zhou, Junhua ^a   Frankl, Fiona E Karet ^b   Gurnell, Mark ^a   Happerfield, Lisa ^c   Marker, Alison ^c   Bienz, Mariann ^d   Azizan, Elena A B ^e   Brown, Morris J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^e UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; BETA CATENIN; G PROTEIN COUPLED RECEPTOR; WNT PROTEIN; ALDOSTERONE; CTNNB1 PROTEIN, HUMAN; GONADORELIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR;

ADRENAL CORTEX CELL; ADRENAL GLAND; ADULT; ARTICLE; CASE REPORT; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CLINICAL FEATURE; CTNNB1 GENE; FEMALE; GENE; GENE EXPRESSION; GNRHR GENE; HISTOPATHOLOGY; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; LHCGR GENE; MENOPAUSE; PREGNANCY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SOMATIC MUTATION; STEM CELL; ADENOMA; ADRENAL TUMOR; GENETICS; HYPOKALEMIA; METABOLISM; MIDDLE AGED; PATHOLOGY; POSTMENOPAUSE; PREGNANCY COMPLICATION; SECRETION (PROCESS); UPREGULATION;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADULT; ALDOSTERONE; BETA CATENIN; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; MIDDLE AGED; POSTMENOPAUSE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RECEPTORS, LH; RECEPTORS, LHRH; UP-REGULATION;

EID: 84943514836     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1504869     Document Type: Article

References (25)

1. Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045-50.
2. Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293-300.
3. Savard S, Amar L, Plouin PF, Steichen O. Cardiovascular complications associated with primary aldosteronism: A controlled cross-sectional study. Hypertension 2013; 62: 331-6.
4. Kim AC, Reuter AL, Zubair M, et al. Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development 2008; 135: 2593-602.
5. Hatano O, Takakusu A, Nomura M, Morohashi K. Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1. Genes Cells 1996; 1: 663-71.
6. Berthon A, Martinez A, Bertherat J, Val P. Wnt/β-catenin signalling in adrenal physiology and tumour development. Mol Cell Endocrinol 2012; 351: 87-95.
7. Tissier F, Cavard C, Groussin L, et al. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res 2005; 65: 7622-7.
8. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787-90.
9. Al-Ali NA, El-Sandabesee D, Steel SA, Roland JM. Conn's syndrome in pregnancy successfully treated with amiloride. J Obstet Gynaecol 2007; 27: 730-1.
10. Azizan EA, Lam BY, Newhouse SJ, et al. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosaand zona fasciculata-like tumors. J Clin Endocrinol Metab 2012; 97(5): E819-E829.
11. Azizan EA, Poulsen H, Tuluc P, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet 2013; 45: 1055-60.
12. Zhou J, Shaikh LH, Neogi SG, et al. DACH1, a zona glomerulosa selective gene in the human adrenal, activates transforming growth factor-β signaling and suppresses aldosterone secretion. Hypertension 2015; 65: 1103-10.
13. Saner-Amigh K, Mayhew BA, Mantero F, et al. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J Clin Endocrinol Metab 2006; 91: 1136-42.
14. Albiger NM, Sartorato P, Mariniello B, et al. A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion? Eur J Endocrinol 2011; 164: 405-12.
15. Nakamura Y, Hattangady NG, Ye P, et al. Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA). Mol Cell Endocrinol 2014; 384: 102-8.
16. El Ghorayeb N, Bourdeau I, Lacroix A. Multiple aberrant hormone receptors in Cushing's syndrome. Eur J Endocrinol 2015 May 13 (Epub ahead of print).
17. Shigematsu K, Nishida N, Sakai H, et al. Primary aldosteronism with aldosterone-producing adenoma consisting of pure zona glomerulosa-type cells in a pregnant woman. Endocr Pathol 2009; 20: 66-72.
18. Gummow BM, Winnay JN, Hammer GD, et al. Convergence of Wnt signaling and SF-1 on transcription of the rat inhibin α gene. J Biol Chem 2003; 278: 26572-9.
19. Law NC, Weck J, Kyriss B, Nilson JH, Hunzicker-Dunn M. Lhcgr expression in granulosa cells: roles for PKA-phosphorylated β-catenin, TCF3, and FOXO1. Mol Endocrinol 2013; 27: 1295-310.
20. Kim AC, Barlaskar FM, Heaton JH, et al. In search of adrenocortical stem and progenitor cells. Endocr Rev 2009; 30: 241-63.
21. Siler-Khodr TM, Khodr GS, Valenzuela G. Immunoreactive gonadotropinreleasing hormone level in maternal circulation throughout pregnancy. Am J Obstet Gynecol 1984; 150: 376-9.
22. Barlaskar FM, Spalding AC, Heaton JH, et al. Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. J Clin Endocrinol Metab 2009; 94: 204-12.
23. Chakravarti S, Collins WP, Forecast JD, Newton JR, Oram DH, Studd JWW. Hormonal profiles after the menopause. Br Med J 1976; 2: 784-7.
24. Lacroix A, Hamet P, Boutin JM. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N Engl J Med 1999; 341: 1577-81.
25. Eguchi K, Hoshide S, Nagashima S, Maekawa T, Sasano H, Kario K. An adverse pregnancy-associated outcome due to overlooked primary aldosteronism. Intern Med 2014; 53: 2499-504.